Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

In conclusion, our results introduced the alteration patterns of serum gangliosides in breast cancer and suggested serum GM3 as a potential diagnostic biomarker in breast cancer diagnosis and luminal B subtype distinction.
Source: Glycoconjugate Journal - Category: Biochemistry Source Type: research